Acimtamig (AFM13) is a bispecific innate cell engager targeting CD30 and CD16A. This therapeutic agent facilitates the selective cross-linking between natural killer (NK) cells, through CD16A engagement, and CD30-expressing tumor cells. The dual binding capability of Acimtamig enhances the cytotoxic potential of NK cells against targeted tumor cells, making it an invaluable tool for investigating the pathophysiology and potential treatments of peripheral T-cell lymphoma (PTCL).
Acimtamig (AFM13) is a bispecific innate cell engager targeting CD30 and CD16A. This therapeutic agent facilitates the selective cross-linking between natural killer (NK) cells, through CD16A engagement, and CD30-expressing tumor cells. The dual binding capability of Acimtamig enhances the cytotoxic potential of NK cells against targeted tumor cells, making it an invaluable tool for investigating the pathophysiology and potential treatments of peripheral T-cell lymphoma (PTCL).
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
